Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|October 5, 2012
Combining galantamine and memantine in multitargeted, new chemical entities potentially useful in Alzheimer's diseaseElena Simoni, Simona Daniele, Giovanni Bottegoni, et al.
Future Medicinal Chemistry|June 21, 2017
Multitarget drug design strategy in Alzheimer's disease: focus on cholinergic transmission and amyloid-β aggregationElena Simoni, Manuela Bartolini, Izuddin F Abu, et al.
European Journal of Medicinal Chemistry|July 14, 2019
Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's diseaseMichela Rosini, Elena Simoni, Roberta Caporaso, et al.
Journal of Medicinal Chemistry|November 8, 2011
Synthesis of monomeric derivatives to probe memoquin's bivalent interactionsMaria Laura Bolognesi, GianPaolo Chiriano, Manuela Bartolini, et al.
Frontiers in Pharmacology|September 14, 2020
Targeting Cytokine Release Through the Differential Modulation of Nrf2 and NF-κB Pathways by Electrophilic/Non-Electrophilic CompoundsFrancesca Fagiani, Michele Catanzaro, Erica Buoso, et al.
European Journal of Medicinal Chemistry|September 21, 2023
Galantamine-memantine hybrids for Alzheimer's disease: The influence of linker rigidity in biological activity and pharmacokinetic propertiesFilippo Basagni, Jose A Ortega, Sine M Bertozzi, et al.
Journal of Medicinal Chemistry|August 8, 2025
Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based InhibitorsGiambattista Marotta, Francesca Massenzio, Jose Ortega, et al.
Journal of Medicinal Chemistry|September 14, 2007
Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's diseaseMaria Laura Bolognesi, Rita Banzi, Manuela Bartolini, et al.
Pageof 8